Saturday 17 October 2026
Export QGEN’s income statement to Excel — free account
QIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 7.94%, free cash flow grew 30.5% and total debt rose 13.8%, each against the same quarter a year earlier.
46.13
0.04
−0.09%
Follow QGEN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 11.93% | 11.93% | 11.57% | 11.29% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 7 | 8 | 7 | |
| 6.99% | 7.10% | 7.10% | 6.32% | ||
ROIC |
6.62% | 6.27% | 6.72% | 7.43% | |
Return on Tangible Assets |
20.48% | 20.35% | 17.65% | 16.51% | |
Average Days of Receivables |
67.75 | 68.97 | 70.31 | 66.20 | |
Free Cash Flow per Share |
2.14 | 1.95 | 2.06 | 2.29 | |
Free Cash Flow |
440.60 | 403.87 | 447.20 | 472.50 | |
Capital Expenditures |
(213.87) | (211.34) | (207.13) | (185.20) | |
| Other line items | |||||
Cash ROIC |
7.60% | 7.18% | 6.85% | 6.33% | |
Accounts Receivable Turnover |
5.42 | 5.69 | 5.56 | 5.74 | |
Accounts Payable Turnover |
9.84 | 10.79 | 10.14 | 9.93 | |
Inventory Turnover |
2.63 | 2.70 | 2.72 | 2.49 | |
Average Days of Payables |
36.36 | 35.79 | 33.55 | 35.76 | |
Days of Inventory on Hand |
143.16 | 141.53 | 139.39 | 138.79 | |
Tax Rate |
(0.11) | (0.12) | (0.13) | (0.20) | |
Research and Development Expense of Revenue |
9.27% | 9.15% | 8.97% | 9.12% | |
Selling, General and Administrative Expense of Revenue |
27.91% | 28.02% | 27.93% | 27.60% | |
Share Based Compensation of Revenue |
2.09% | 2.27% | 2.41% | 2.16% | |
Interest Coverage |
11.30 | 11.75 | 14.01 | 14.17 | |
Operating CF/Net income |
1.60 | 1.53 | 1.54 | 1.62 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.21 | 0.22 | |
Capex/Depreciation |
(1.04) | (1.03) | (1.05) | (0.95) | |
Revenue per Share |
10.18 | 10.14 | 9.62 | 10.05 | |
Operating CF per Share |
3.17 | 2.97 | 3.01 | 3.19 | |
Capex per Share |
(1.04) | (1.02) | (0.95) | (0.90) | |
Capex to Sales |
0.10 | 0.10 | 0.10 | 0.09 |
Columns are period end dates